SaintMed Past Earnings Performance
Past criteria checks 2/6
SaintMed has been growing earnings at an average annual rate of 16.6%, while the Healthcare industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 16.7% per year. SaintMed's return on equity is 8.8%, and it has net margins of 9.6%.
Key information
16.6%
Earnings growth rate
12.3%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 16.7% |
| Return on equity | 8.8% |
| Net Margin | 9.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How SaintMed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 827 | 79 | 207 | 0 |
| 30 Sep 23 | 750 | 54 | 203 | 0 |
| 30 Jun 23 | 1,009 | 110 | 205 | 0 |
| 31 Mar 23 | 1,470 | 168 | 208 | 0 |
| 31 Dec 22 | 2,010 | 297 | 218 | 0 |
| 30 Sep 22 | 2,278 | 347 | 222 | 0 |
| 30 Jun 22 | 2,535 | 469 | 232 | 0 |
| 31 Mar 22 | 2,174 | 448 | 228 | 0 |
| 31 Dec 21 | 1,621 | 320 | 217 | 0 |
| 30 Sep 21 | 1,413 | 303 | 208 | 0 |
| 30 Jun 21 | 856 | 123 | 192 | 0 |
| 31 Mar 21 | 704 | 88 | 179 | 0 |
| 31 Dec 20 | 661 | 78 | 172 | 0 |
| 30 Sep 20 | 569 | 48 | 171 | 0 |
| 31 Dec 19 | 619 | 60 | 172 | 0 |
| 31 Dec 18 | 506 | 35 | 78 | 0 |
| 31 Dec 17 | 469 | 39 | 137 | 0 |
| 31 Dec 16 | 565 | 55 | 135 | 0 |
Quality Earnings: SMD-R has high quality earnings.
Growing Profit Margin: SMD-R's current net profit margins (9.6%) are lower than last year (14.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SMD-R's earnings have grown by 16.6% per year over the past 5 years.
Accelerating Growth: SMD-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SMD-R had negative earnings growth (-73.3%) over the past year, making it difficult to compare to the Healthcare industry average (-29.6%).
Return on Equity
High ROE: SMD-R's Return on Equity (8.8%) is considered low.